☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
$2.2B
GSK and Alector Sign $2.2B Collaboration to Develop Therapies for Neurodegenerative Diseases
July 5, 2021
Merck to Acquire Peloton Therapeutics for $2.2B
May 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
